Geode Capital Management »

Lyell Immunopharma shares owned by Geode Capital Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.5M 4.0M 1.38
2024-06-30 $5.8M 4.0M 1.45
2024-03-31 $9.0M 4.0M 2.23
2023-09-30 $5.4M 3.7M 1.47
2023-06-30 $11M 3.4M 3.18
2023-03-31 $7.5M 3.2M 2.36
2022-12-31 $11M 3.1M 3.47
2022-09-30 $22M 3.0M 7.33
2022-06-30 $12M 1.9M 6.52
2022-03-31 $7.3M 1.5M 5.05
2021-12-31 $4.3M 559k 7.74
2021-09-30 $7.9M 532k 14.80
2021-06-30 $2.8M 174k 16.24